Studies on the omission of RT in older women with a low recurrence of hormone receptor-positive or HER2-negative breast cancer (as a better prognosis) have been conducted, but studies including women aged ≥80 years are scant [8,9,10,11,12]. The gene discussed is ERBB2; the disease is breast carcinoma.